Management of Persistent Candida tropicalis Fungemia

Immediate Management Steps

For patients with persistent Candida tropicalis fungemia, the Infectious Diseases Society of America recommends removing central venous catheters if present, as this is a critical intervention for persistent candidemia 1, 2
The American College of Physicians suggests obtaining follow-up blood cultures daily until clearance is documented to guide therapy 1, 3
The Centers for Disease Control and Prevention recommend performing susceptibility testing on isolates to confirm resistance patterns 1, 3
A diagnostic workup should be conducted to identify potential metastatic foci of infection, including a dilated funduscopic examination to rule out endophthalmitis and imaging of the genitourinary tract, liver, and spleen if blood cultures remain positive 1, 3

The European Society of Clinical Microbiology and Infectious Diseases recommends switching to lipid formulation amphotericin B (3-5 mg/kg daily) as the most effective alternative for persistent C. tropicalis fungemia 1, 3
If lipid formulation amphotericin B is not available, the National Institutes of Health suggest considering conventional amphotericin B deoxycholate (0.7-1.0 mg/kg/day) 4
Higher doses of echinocandins, such as caspofungin 150 mg daily or micafungin 150 mg daily, may be considered, though evidence for this approach is limited 1

The Infectious Diseases Society of America recommends continuing antifungal therapy for at least 2 weeks after documented clearance of Candida from the bloodstream 1, 2, 3
Therapy should be continued until resolution of symptoms attributable to candidemia 1, 3
For neutropenic patients, therapy should be continued until resolution of neutropenia 2, 3
Longer therapy will be required if metastatic complications are identified 1, 3

The American Society of Hematology recommends considering G-CSF–mobilized granulocyte transfusions in neutropenic patients with persistent candidemia if neutropenia is expected to be prolonged 1
Strict glycemic control is recommended, particularly in diabetic patients, according to the American Diabetes Association 5

Daily blood cultures should be obtained until clearance is documented 1, 3
Monitoring for drug toxicity, particularly with amphotericin B formulations, is crucial, including renal function tests and electrolyte monitoring 1
Repeat imaging studies should be conducted if metastatic infection is suspected 1, 3